Suppr超能文献

中国 2 型糖尿病患者 25 羟维生素 D 水平与非酒精性脂肪性肝病的相关性:一项横断面研究

Correlation Between 25 Hydroxyvitamin D Levels and Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.

作者信息

Xiu Lei, Jiang Tao, Yao Xiao-Ai, Wen Zhen

机构信息

Department of Endocrinology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.

出版信息

Int J Gen Med. 2021 Jul 1;14:3099-3107. doi: 10.2147/IJGM.S319449. eCollection 2021.

Abstract

PURPOSE

We aimed to analyze the serum vitamin D level in Chinese patients with type 2 diabetes mellitus (T2DM) and discuss its correlation with nonalcoholic fatty liver disease (NAFLD).

PATIENTS AND METHODS

A total of 300 patients with T2DM (92 patients without NAFLD and 208 patients with NAFLD) were enrolled, and 25-hydroxyvitamin D [25-(OH)D] levels were compared between the two groups. Second, the NAFLD fibrosis score (NFS) and fatty liver index (FLI) were used to group patients with T2DM complicated by NAFLD, and the differences in serum 25-(OH)D in patients with different degrees of liver fibrosis were compared. Third, multiple regression analysis was used to analyze the independent predictors of liver fibrosis in patients with T2DM complicated by NAFLD.

RESULTS

The level of 25-(OH)D in patients with T2DM complicated by NAFLD was significantly lower than that in patients with T2DM alone. Based on the NFS and FLI, the 25-(OH)D level of the hepatic fibrosis subgroup was significantly lower than that of the subgroup without liver fibrosis. 25-(OH)D was found to be an independent predictor of liver fibrosis in patients with T2DM complicated by NAFLD.

CONCLUSION

The serum 25-(OH)D level in patients with T2DM complicated by NAFLD was significantly reduced, and the 25-(OH)D level showed a gradual downward trend with the degree of liver fibrosis. Low concentrations of 25-(OH)D may be indicative of the degree of liver fibrosis in diabetic patients.

摘要

目的

我们旨在分析中国2型糖尿病(T2DM)患者的血清维生素D水平,并探讨其与非酒精性脂肪性肝病(NAFLD)的相关性。

患者与方法

共纳入300例T2DM患者(92例无NAFLD,208例有NAFLD),比较两组患者的25-羟维生素D[25-(OH)D]水平。其次,采用NAFLD纤维化评分(NFS)和脂肪肝指数(FLI)对合并NAFLD的T2DM患者进行分组,比较不同程度肝纤维化患者血清25-(OH)D的差异。第三,采用多元回归分析分析合并NAFLD的T2DM患者肝纤维化的独立预测因素。

结果

合并NAFLD的T2DM患者的25-(OH)D水平显著低于单纯T2DM患者。根据NFS和FLI,肝纤维化亚组的2�-(OH)D水平显著低于无肝纤维化亚组。发现25-(OH)D是合并NAFLD的T2DM患者肝纤维化的独立预测因素。

结论

合并NAFLD的T2DM患者血清25-(OH)D水平显著降低,且25-(OH)D水平随肝纤维化程度呈逐渐下降趋势。低浓度的25-(OH)D可能提示糖尿病患者的肝纤维化程度。

相似文献

4
The association of serum FGF23 and non-alcoholic fatty liver disease is independent of vitamin D in type 2 diabetes patients.
Clin Exp Pharmacol Physiol. 2018 Jul;45(7):668-674. doi: 10.1111/1440-1681.12933. Epub 2018 Apr 25.

引用本文的文献

2
Vitamin D improves hepatic steatosis in NAFLD regulation of fatty acid uptake and β-oxidation.
Front Endocrinol (Lausanne). 2023 Mar 22;14:1138078. doi: 10.3389/fendo.2023.1138078. eCollection 2023.

本文引用的文献

3
The non-invasive assessment of hepatic fibrosis.
J Formos Med Assoc. 2021 Feb;120(2):794-803. doi: 10.1016/j.jfma.2020.08.019. Epub 2020 Aug 26.
4
Serum Vitamin D Levels and Risk of Liver Cancer: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies.
Nutr Cancer. 2021;73(8):1-9. doi: 10.1080/01635581.2020.1797127. Epub 2020 Jul 24.
5
Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 Diabetes.
J Diabetes Res. 2018 Nov 4;2018:6354787. doi: 10.1155/2018/6354787. eCollection 2018.
6
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes.
Diabetes Metab. 2019 Sep;45(4):347-355. doi: 10.1016/j.diabet.2018.10.001. Epub 2018 Oct 10.
7
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis.
Medicine (Baltimore). 2017 Sep;96(39):e8179. doi: 10.1097/MD.0000000000008179.
10
Osteoblast-osteoclast interactions.
Connect Tissue Res. 2018 Mar;59(2):99-107. doi: 10.1080/03008207.2017.1290085. Epub 2017 Mar 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验